Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Mar-15-12 | Dec-31-11 | Mar-15-11 | Dec-31-10 |
| Revenues | 58.7 | 86.3 | 134.2 | 112.6 | 152.8 | 152.8 | 216.7 | 216.7 |
| Revenue growth | -32.0% | -35.7% | 19.2% | -26.3% | -29.5% | -29.5% | 54.3% | 54.3% |
| Cost of goods sold | 48.0 | 76.8 | 125.9 | 113.9 | 121.7 | 121.7 | 140.9 | 140.9 |
| Gross profit | 10.7 | 9.5 | 8.3 | -1.2 | 31.1 | 31.1 | 75.8 | 75.8 |
| Gross margin | 18.2% | 11.0% | 6.2% | -1.1% | 20.4% | 20.4% | 35.0% | 35.0% |
| Selling, general and administrative | 13.5 | 17.1 | 23.8 | 70.5 | 81.2 | 81.2 | 76.4 | 76.4 |
| Research and development | 19.7 | 26.7 | 38.6 | | | | | |
| EBITA | -22.4 | -34.1 | -54.0 | -71.7 | -50.1 | -50.1 | -0.5 | -0.5 |
| EBITA margin | -38.2% | -39.6% | -40.2% | -63.7% | -32.8% | -32.8% | -0.2% | -0.2% |
| Amortization of intangibles | 0.0 | 0.2 | 0.1 | | | | | |
| EBIT | -22.5 | -34.3 | -54.1 | -71.7 | -50.1 | -50.1 | -0.5 | -0.5 |
| EBIT margin | -38.3% | -39.8% | -40.3% | -63.7% | -32.8% | -32.8% | -0.2% | -0.2% |
| Pre-tax income | -23.5 | -38.9 | -54.0 | -69.9 | -49.3 | -49.3 | 1.0 | 1.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | -0.3 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | |
| Net income | -23.5 | -38.9 | -54.0 | -69.9 | -49.3 | -49.3 | 1.3 | 1.3 |
| Net margin | -40.0% | -45.1% | -40.2% | -62.0% | -32.3% | -32.3% | 0.6% | 0.6% |
| |
| Diluted EPS | ($0.27) | ($0.45) | ($0.67) | ($0.99) | | ($0.73) | | $0.02 |
| Shares outstanding (diluted) | 88.2 | 85.8 | 81.0 | 70.6 | | 67.6 | | 63.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|